Skip to main content

GOLDMAN SACHS GROUP INC

Position in OVID — Ovid Therapeutics Inc.

CIK 886982 NEW YORK, NY

Position in OVID

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$894,940
+$555,620 QoQ
Shares Held
332,692
+117.7% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OVID Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. OVID ranks #259 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OVID

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $894,940 332,692
2026-03-31 $339,320 152,847
2025-12-31 $277,844 170,457
2025-09-30 $37,072 28,517
2025-06-30 $93,661 283,824
2025-03-31 $32,583 104,435
2024-12-31 $185,046 198,123
2024-09-30 $153,728 130,279
2024-06-30 $97,528 126,826
2024-03-31 $179,900 58,984
2023-12-31 $198,979 61,795
2023-09-30 $217,942 56,756
2023-06-30 $216,879 66,122
2023-03-31 $28,828 11,174
2022-12-31 $28,188 15,155
2022-09-30 $66,375 36,074
2022-06-30 $93,741 43,601
2022-03-31 $142,388 45,347
2021-12-31 $158,538 49,389
2021-09-30 $327,750 97,545
2021-06-30 $444,065 113,572
2021-03-31 $3,021,290 751,565
2020-12-31 $1,096,198 474,545
2020-09-30 $295,683 51,513
2020-06-30 $845,146 114,674
2020-03-31 $406,027 136,251